AbbVie mum on plans for ImmunoGen employees, HQ


AbbVie is expected to spend $10.1 billion buying ImmunoGen Inc. by mid-2024, but the pharma firm isn't saying what'll happen to the Waltham company's employees or headquarters.

Previous Baltimore planning commission delays vote on Harborplace legislation
Next Mother-daughter duo Lisa and Taylor Clifft take on Tacos 4 Life as franchisees